Nonalcoholic fatty liver disease (NAFLD) is generally associated with obesity and the related
comorbidities but it can also develop in subjects with a body mass index (BMI) within the …

Nonalcoholic fatty liver disease (NAFLD) is commonly diagnosed in obese or overweight
individuals. However, lean individuals with NAFLD are not rare but represent one significant …

The prevalence of nonalcoholic fatty liver disease (NAFLD) has increased rapidly and is
associated with obesity in epidemiology and pathogenesis. A new study reports that hepatic …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide, with
an estimated prevalence of 25% globally. NAFLD is closely associated with metabolic …

BACKGROUND Nonalcoholic fatty liver disease (NAFLD) has been consistently associated
with obesity and insulin resistance. Nonalcoholic steatohepatitis (NASH) is a histological …

Objective The full phenotypic expression of non-alcoholic fatty liver disease (NAFLD) in lean
subjects is incompletely characterised. We aimed to investigate prevalence, characteristics …

Introduction While patients with non-alcoholic fatty liver disease (NAFLD) are mostly
overweight or obese, some are lean. Methods In a community-based follow-up study …

The high prevalence of non‐alcoholic fatty liver disease (NAFLD) has made the condition an
important public health issue. Two clinical entities are manifestations of NAFLD, namely, non …

A small proportion of lean patients develop non-alcoholic fatty liver disease (NAFLD). We
aimed to report the histological picture of lean NAFLD in comparison to overweight and …

Non-alcoholic fatty liver disease (NAFLD) is a frequent syndrome encompassing fatty liver
alone and steatohepatitis (NASH). Often asymptomatic, the suspicion arises because of …